Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2014
ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapyFan Lin, Mark C de Gooijer, Eloy Moreno Roig, et al.
Molecular Cancer Therapeutics|November 7, 2013
OATP1A/1B transporters affect irinotecan and SN-38 pharmacokinetics and carboxylesterase expression in knockout and humanized transgenic miceDilek Iusuf, Marion Ludwig, Ahmed Elbatsh, et al.
Molecular Cancer Therapeutics|December 13, 2002
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin CJohn D Allen, Arnold van Loevezijn, Jeany M Lakhai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbineJame Abraham, Maureen Edgerly, Richard Wilson, et al.
BMC Cancer|December 18, 2009
Concerns about anti-angiogenic treatment in patients with glioblastoma multiformeJoost J C Verhoeff, Olaf van Tellingen, An Claes, et al.
Molecular Cancer Therapeutics|August 30, 2008
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type miceSerena Marchetti, Nienke A de Vries, Tessa Buckle, et al.
Nature Communications|May 30, 2013
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicinBaoxu Pang, Xiaohang Qiao, Lennert Janssen, et al.
British Journal of Cancer|May 9, 2018
Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell divisionAna Rita R Maia, Simon Linder, Ji-Ying Song, et al.
Communications Biology|October 3, 2024
Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemiaTamara C A I Verbeek, Kirsten S Vrenken, Susan T C J M Arentsen-Peters, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2017
A serum and platelet-rich plasma serotonin assay using liquid chromatography tandem mass spectrometry for monitoring of neuroendocrine tumor patientsCatharina M Korse, Johanna C G M Buning-Kager, Theodora C Linders, et al.
Pageof 14